Rocky mountain spotted fever: A seasonal alert

Clinical Infectious Diseases

Volumn 20, Issue 5, 1995, Pages 1111-1117

  Walker, David H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANOREXIA; EDEMA; FEVER; HEADACHE; HUMAN; HYPOTENSION; HYPOVOLEMIA; MENINGOENCEPHALITIS; MYALGIA; NAUSEA; PRIORITY JOURNAL; RASH; REVIEW; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; TICK BORNE DISEASE; UREMIA; VOMITING;

HUMAN; ROCKY MOUNTAIN SPOTTED FEVER; SEASONS;

EID: 0029061763     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.5.1111     Document Type: Article

References (33)

1. Centers for Disease Control. Rocky Mountain spotted fever and human Ehrlichiosis-United States, 1989MMWR Morb Mortal Wkly Rep 1990;39:281-4.
2. Centers for Disease Control. Rocky Mountain spotted fever-United States, 1990. MMWR Morb Mortal Wkly Rep 1991;40:451-9.
3. Parker RR. Rocky Mountain spotted fever: results of fifteen years’ pro phylactic vaccination. Am J Trop Med 1941;21:369-83.
4. Kaplowitz LG, Fischer JJ, Sparling PF. Rocky Mountain spotted fever: a clinical dilemma. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases, Vol. 2. New York: McGraw- Hill, 1981: 89-108.
5. Helmick CG, Bernard KW, D’Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984;150:480-8.
6. Wilfert CM, MacCormack JN, Kleeman K, et al. Epidemiology of Rocky Mountain spotted fever as determined by active surveillance. J Infect Dis 1984; 150:469-79.
7. Sexton DJ, Corey GR. Rocky Mountain “spotless” and “almost spot less” fever: a wolf in sheep’s clothing. Clin Infect Dis 1992; 15: 439-48.
8. Sexton DJ, Burgdorfer W. Clinical and epidemiologic features of Rocky Mountain spotted fever in Mississippi, 1933-1973. South Med J 1975;68:1529-35.
9. Hattwick MAW, O’Brien RJ, Hanson BF. Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med 1976;84:732-9.
10. Harrell GT, Aikawa JK. Pathogenesis of circulatory failure in Rocky Mountain spotted fever. Alterations in the blood volume and the thiocyanate space at various stages of the disease. Arch Intern Med 1949;83:331-47.
11. Haynes RE, Sanders DY, Cramblett HG. Rocky Mountain spotted fever in children. J Pediatr 1970;76:685-93.
12. Davidson MG. Breitschwerdt EB, Walker DH, et al. Vascular perme ability and coagulation during Rickettsia rickettsii infection in dogs. Am J Vet Res 1990;51:165-70.
13. Middleton DB. Rocky Mountain spotted fever: gastrointestinal and lab oratory manifestations. South Med J 1978;71:629-32.
14. Parker RR. Rocky Mountain spotted fever. JAMA 1938;110:1185-8, 1273-8.
15. Walker DH, Hawkins HR, Hudson P. Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 1983;107:121-5.
16. Walker DH, Raoult D. Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers). Infectious diseases. 4th ed. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995:1721-7.
17. Walker DH, Fishbein DB. Epidemiology of rickettsial diseases. Eur J Epidemiol 1991;7:237-45.
18. Morrison RE, Lancaster L, Lancaster DJ, Land MA. Rocky Mountain spotted fever in the elderly. J Am Geriatr Soc 1991;39:205-8.
19. Kleeman KT, Hicks JL, Anacker RL, et al. Early detection of antibody to Rickettsia rickettsii: a comparison of four serological methods: indirect hemagglutination, indirect fluorescent antibody, latex agglutination, and complement fixation. In: Burgdorfer W, Anacker RL, eds. Rickettsiae and rickettsial diseases. New York: Academic Press, 1981:171-8.
20. Hechemy KE, Michaelson EE, Anacker RL, et al. Evaluation of latex- Rickettsia rickettsii test for Rocky Mountain spotted fever in 11 laboratories. J Clin Microbiol 1983; 18:938-46.
21. Kaplan JE, Schonberger LB. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg 1986;35:840-4.
22. Walker DH, Burday MS, Folds JD. Laboratory diagnosis of Rocky Mountain spotted fever. South Med J 1980;73:1443-9.
23. Kaplowitz LG, Lange JV, Fischer JJ, Walker DH. Correlation of rick ettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever. Arch Intern Med 1983; 143:1149-51.
24. Walker DH, Cain BG, Lange J V, Harrison A. Pathologic and rickettsial events in tetracycline-treated experimental Rocky Mountain spotted fever. In: Burgdorfer W, Anacker RL, eds. Rickettsiae and rickettsial diseases. New York: Academic Press, 1981:347-62.
25. Walker DH, Cain BG, Olmstead PM. Laboratory diagnosis of Rocky Mountain spotted fever by immunofluorescent demonstration of Rickettsia rickettsii in cutaneous lesions. Am J Clin Pathol 1978;69:619-23.
26. Drancourt M, George F, Brouqui P. Sampol J, Raoult D. Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. J Infect Dis 1992;166:660-3.
27. Tzianabos T, Anderson BE, McDade JE. Detection of Rickettsia rick ettsii DNA in clinical specimens by using polymerase chain reaction technology. J Clin Microbiol 1989;27:2866-8.
28. Sexton DJ, Kanj SS, Wilson K, et al. The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. Am J Trop Med Hyg 1994;50:59-63.
29. Williams WJ, Radulovic S, Dasch GA, et al. Identification of Rickettsia conorii infection by polymerase chain reaction in a soldier returning from Somalia. Clin Infect Dis 1994; 19:93-9.
30. Marrero M, Raoult D. Centrifugation-shell vial technique for rapid de tection of Mediterranean spotted fever rickettsia in blood culture. Am J Trop Med Hyg 1989;40:197-9.
31. Abramson JS, Givncr LB. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age? Pediatrics 1990;86:123-4.
32. Grossman ER, Walchek A, Freedman H. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 1971;47:567-70.
33. Kaplowitz LG, Robertson GL. Hyponatremia in Rocky Mountain spotted fever: role of antidiuretic hormone. Ann Intern Med 1983;98:334-5.